Stockreport

KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data [Yahoo! Finance]

Kura Oncology, Inc.  (KURA) 
Last kura oncology, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.kuraoncology.com/investor-relations
PDF The analysis focused on patients with clear cell renal cell carcinoma (ccRCC) who had previously been treated with cabozantinib, a population that typically showed limit [Read more]